Kanabinoid Zehirlenmeleri
Özet
Esrar (Cannabis sativa), etken maddesi delta-9-tetrahidrokanabinol (THC) olan, yağ dokusunda eriyerek vücutta 28 günden fazla kalabilen ve tüm dünyada en sık kullanılan illegal maddedir. Kullanıcıların %10'unda bağımlılık oluşturan esrar, altta yatan şizofreniyi ortaya çıkarabilir veya psikotik semptomları artırabilir. Dünya genelinde ve Türkiye'de özellikle 18-25 yaş arası erkeklerde yaygın görülen bu madde, merkezi sinir sistemindeki CB1 ve periferdeki CB2 reseptörleri üzerinden etki gösterir. İnhalasyonla alındığında etkileri yarım saat içinde başlayıp 2-4 saat sürerken, oral alımda 12 saati aşabilmektedir. Esrar intoksikasyonunda taşikardi, ağız kuruluğu, hipo/hipertansiyon, dezoryantasyon ve anksiyete görülür; tanısı klinik olarak konulup tedavisi destekleyicidir. Yoksunluğunda ise sinirlilik, uykusuzluk ve iştahsızlık öne çıkar. Sentetik kanabinoidler (bonzai, Jamaika vb.) ise doğal kanabinoidlere göre çok daha potent, yüksek bağımlılık yapıcı ve son derece tehlikelidir. Prof. Dr. John W. Huffman tarafından geliştirilen 450 farklı türü bulunan (JWH serisi) bu maddeler; miyokard enfarktüsü, inme, nöbet, koma, ARDS, rabdomiyoliz ve akut böbrek yetmezliği gibi ağır klinik tablolara yol açabilir. Rutin idrar analizlerinde tespit edilemeyen sentetik kanabinoidlerin tedavisinde ajitasyon için benzodiazepinler, hipertermi için eksternal soğutma ve rabdomiyolizi önlemek amacıyla serum fizyolojik infüzyonu uygulanır.
Cannabis (Cannabis sativa) is the most widely used illegal substance in the world whose active ingredient is delta-9-tetrahydrocannabinol (THC), which dissolves in fat tissue and can remain in the body for more than 28 days. Causing addiction in approximately 10% of users, cannabis can trigger underlying schizophrenia or exacerbate psychotic symptoms. Commonly used among young males aged 18-25 both globally and in Turkey, this substance acts through CB1 receptors in the central nervous system and CB2 receptors in the periphery. When inhaled, its effects begin within half an hour and last 2-4 hours, whereas after oral ingestion, the duration can exceed 12 hours. Cannabis intoxication presents with tachycardia, dry mouth, hypo/hypertension, disorientation, and anxiety; its diagnosis is made clinically and treatment is supportive. In withdrawal, irritability, insomnia, and loss of appetite are predominant. Synthetic cannabinoids (bonzai, Jamaica, etc.), on the other hand, are much more potent, highly addictive, and extremely dangerous compared to natural cannabinoids. With 450 different types synthesized by Prof. Dr. John W. Huffman (JWH series), these substances can lead to severe clinical conditions such as myocardial infarction, stroke, seizures, coma, ARDS, rhabdomyolysis, and acute kidney injury. Since synthetic cannabinoids cannot be detected in routine urine analysis, their treatment involves benzodiazepines for agitation, external cooling for hyperthermia, and normal saline infusion to prevent rhabdomyolysis.
Referanslar
Vereinte Nationen, Büro für Drogenkontrolle und Verbrechensbekämpfung. World drug report 2018. 2018.
Swift W, Wong A, Li KM, Arnold JC, McGregor IS. Analysis of Cannabis Seizures in NSW, Australia: Cannabis Potency and Cannabinoid Profile. PLOS ONE. 24 Temmuz 2013;8(7):e70052.
Renard J, Rushlow WJ, Laviolette SR. Effects of Adolescent THC Exposure on the Prefrontal GABAergic System: Implications for Schizophrenia-Related Psychopathology. Front Psychiatry [Internet]. 2018 [a.yer 30 Kasım 2020];9. Erişim adresi: https://www.frontiersin.org/articles/10.3389/fpsyt.2018.00281/full
BAĞIMLILIK İLE MÜCADELE REHBERİ.pdf [İnternet]. [a.yer 30 Kasım 2020]. Erişim adresi: https://hsgm.saglik.gov.tr/depo/birimler/tutun-mucadele-bagimlilik-db/Uyusturucu/Bagimlilikla_Mucadele_Rehberi.pdf
2016 National Survey on Drug Use and Health: Detailed Tables. :2889. Grotenhermen F. Pharmacokinetics and Pharmacodynamics of Cannabinoids. Clin Pharmacokinet. 01 Nisan 2003;42(4):327-60.
McGilveray IJ. Pharmacokinetics of cannabinoids. Pain Res Manag. 2005;10 Suppl A:15A-22A.
Adams IB, Martin BR. Cannabis: pharmacology and toxicology in animals and humans. Addiction. 1996;91(11):1585-614.
Spindle TR, Cone EJ, Schlienz NJ, Mitchell JM, Bigelow GE, Flegel R, vd. Urinary Excretion Profile of 11-Nor-9-Carboxy-Δ9-Tetrahydrocannabinol (THCCOOH) Following Smoked and Vaporized Cannabis Administration in Infrequent Cannabis Users. Journal of Analytical Toxicology. 07 Ocak 2020;44(1):1-14.
Rosenbaum CD, Carreiro SP, Babu KM. Here Today, Gone Tomorrow…and Back Again? A Review of Herbal Marijuana Alternatives (K2, Spice), Synthetic Cathinones (Bath Salts), Kratom, Salvia divinorum, Methoxetamine, and Piperazines. J Med Toxicol. 01 Mart 2012;8(1):15-32.
The “New” Marijuana - Daina L Wells, Carol A Ott, 2011 [İnternet]. [a.yer 01 Aralık 2020]. Erişim adresi: https://journals.sagepub.com/doi/10.1345/aph.1P580?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
Dresen S, Ferreirós N, Pütz M, Westphal F, Zimmermann R, Auwärter V. Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds. J Mass Spectrom. Ekim 2010;45(10):1186-94.
Rose DZ, Guerrero WR, Mokin MV, Gooch CL, Bozeman AC, Pearson JM, vd. Hemorrhagic stroke following use of the synthetic marijuana “spice”. Neurology. 29 Eylül 2015;85(13):1177-9.
Wolff V, Jouanjus E. Strokes are possible complications of cannabinoids use. Epilepsy Behav. 01 Mayıs 2017;70:355-63.